Cargando…
Novel N-phenylcarbamothioylbenzamides with anti-inflammatory activity and prostaglandin E(2) inhibitory properties
A number of 2-((4-ethylphenoxy)methyl)-N-(substituted-phenylcarbamothioyl) benzamides (1a–h) were synthesized via reaction of 2-((4-ethylphenoxy)methyl)benzoyl isothiocyanate (2) as a key intermediate with several substituted primary aromatic amines. The new compounds were characterized by proton nu...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3770517/ https://www.ncbi.nlm.nih.gov/pubmed/24039398 http://dx.doi.org/10.2147/DDDT.S46691 |
_version_ | 1782284095949111296 |
---|---|
author | Limban, Carmen Missir, Alexandru Vasile Fahelelbom, Khairi Mustafa Salem Al-Tabakha, Moawia Mohammad Caproiu, Miron Teodor Sadek, Bassem |
author_facet | Limban, Carmen Missir, Alexandru Vasile Fahelelbom, Khairi Mustafa Salem Al-Tabakha, Moawia Mohammad Caproiu, Miron Teodor Sadek, Bassem |
author_sort | Limban, Carmen |
collection | PubMed |
description | A number of 2-((4-ethylphenoxy)methyl)-N-(substituted-phenylcarbamothioyl) benzamides (1a–h) were synthesized via reaction of 2-((4-ethylphenoxy)methyl)benzoyl isothiocyanate (2) as a key intermediate with several substituted primary aromatic amines. The new compounds were characterized by proton nuclear magnetic resonance ((1)H-NMR), carbon-13 nuclear magnetic resonance ((13)C-NMR), infrared spectrometry (IR), mass spectrometry (MS), and elemental analysis. The anti-inflammatory activity of 1a–h was investigated by acute carrageenan-induced paw edema in mice using the reference drug indomethacin. The results obtained indicated that, of the derivatives developed, 1a and 1d–h exhibited significantly higher anti-inflammatory activity (26.81%–61.45%) when compared with the reference drug indomethacin (22.43%) (P = 0.0490 for 1a, 0.0015 for 1d, 0.0330 for 1f, and P < 0.001 for 1e and 1h). Moreover, the ulcer incidence of 20% for 1e and 1h was clearly lower when compared with the indomethacin group (in which the ulcer incidence was 80%). Of particular note, the ulcer index of 0.2 for 1e was significantly less than that in the indomethacin group (0.6, P = 0.014). Additionally, prostaglandin E(2) (PGE(2)) inhibitory properties were found to be high with 1e (68.32 pg/mL), significantly different from those of the placebo group (530.13 pg/mL, P < 0.001), and equipotent to the effect observed in the indomethacin-pretreated group (96.13 pg/mL, P > 0.05). Moreover, the PGE(2) level of 54.15 pg/mL with 1h was also significantly different from that of the placebo group (P < 0.001) and of the indomethacin group (P < 0.05). The significant inhibition of PGE(2) observed with 1e (68.32 pg/mL) and 1h (54.15 pg/mL) agree with their observed ulcer incidences. Our overall findings for N-phenylcarbamothioylbenzamides 1a–h clearly suggest that the compounds exhibit an anti-inflammatory effect, potently inhibit PGE(2) synthesis, and markedly demonstrate low ulcer incidence. |
format | Online Article Text |
id | pubmed-3770517 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-37705172013-09-13 Novel N-phenylcarbamothioylbenzamides with anti-inflammatory activity and prostaglandin E(2) inhibitory properties Limban, Carmen Missir, Alexandru Vasile Fahelelbom, Khairi Mustafa Salem Al-Tabakha, Moawia Mohammad Caproiu, Miron Teodor Sadek, Bassem Drug Des Devel Ther Original Research A number of 2-((4-ethylphenoxy)methyl)-N-(substituted-phenylcarbamothioyl) benzamides (1a–h) were synthesized via reaction of 2-((4-ethylphenoxy)methyl)benzoyl isothiocyanate (2) as a key intermediate with several substituted primary aromatic amines. The new compounds were characterized by proton nuclear magnetic resonance ((1)H-NMR), carbon-13 nuclear magnetic resonance ((13)C-NMR), infrared spectrometry (IR), mass spectrometry (MS), and elemental analysis. The anti-inflammatory activity of 1a–h was investigated by acute carrageenan-induced paw edema in mice using the reference drug indomethacin. The results obtained indicated that, of the derivatives developed, 1a and 1d–h exhibited significantly higher anti-inflammatory activity (26.81%–61.45%) when compared with the reference drug indomethacin (22.43%) (P = 0.0490 for 1a, 0.0015 for 1d, 0.0330 for 1f, and P < 0.001 for 1e and 1h). Moreover, the ulcer incidence of 20% for 1e and 1h was clearly lower when compared with the indomethacin group (in which the ulcer incidence was 80%). Of particular note, the ulcer index of 0.2 for 1e was significantly less than that in the indomethacin group (0.6, P = 0.014). Additionally, prostaglandin E(2) (PGE(2)) inhibitory properties were found to be high with 1e (68.32 pg/mL), significantly different from those of the placebo group (530.13 pg/mL, P < 0.001), and equipotent to the effect observed in the indomethacin-pretreated group (96.13 pg/mL, P > 0.05). Moreover, the PGE(2) level of 54.15 pg/mL with 1h was also significantly different from that of the placebo group (P < 0.001) and of the indomethacin group (P < 0.05). The significant inhibition of PGE(2) observed with 1e (68.32 pg/mL) and 1h (54.15 pg/mL) agree with their observed ulcer incidences. Our overall findings for N-phenylcarbamothioylbenzamides 1a–h clearly suggest that the compounds exhibit an anti-inflammatory effect, potently inhibit PGE(2) synthesis, and markedly demonstrate low ulcer incidence. Dove Medical Press 2013-08-28 /pmc/articles/PMC3770517/ /pubmed/24039398 http://dx.doi.org/10.2147/DDDT.S46691 Text en © 2013 Limban et al. This work is published by Dove Medical Press Ltd, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Ltd, provided the work is properly attributed. |
spellingShingle | Original Research Limban, Carmen Missir, Alexandru Vasile Fahelelbom, Khairi Mustafa Salem Al-Tabakha, Moawia Mohammad Caproiu, Miron Teodor Sadek, Bassem Novel N-phenylcarbamothioylbenzamides with anti-inflammatory activity and prostaglandin E(2) inhibitory properties |
title | Novel N-phenylcarbamothioylbenzamides with anti-inflammatory activity and prostaglandin E(2) inhibitory properties |
title_full | Novel N-phenylcarbamothioylbenzamides with anti-inflammatory activity and prostaglandin E(2) inhibitory properties |
title_fullStr | Novel N-phenylcarbamothioylbenzamides with anti-inflammatory activity and prostaglandin E(2) inhibitory properties |
title_full_unstemmed | Novel N-phenylcarbamothioylbenzamides with anti-inflammatory activity and prostaglandin E(2) inhibitory properties |
title_short | Novel N-phenylcarbamothioylbenzamides with anti-inflammatory activity and prostaglandin E(2) inhibitory properties |
title_sort | novel n-phenylcarbamothioylbenzamides with anti-inflammatory activity and prostaglandin e(2) inhibitory properties |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3770517/ https://www.ncbi.nlm.nih.gov/pubmed/24039398 http://dx.doi.org/10.2147/DDDT.S46691 |
work_keys_str_mv | AT limbancarmen novelnphenylcarbamothioylbenzamideswithantiinflammatoryactivityandprostaglandine2inhibitoryproperties AT missiralexandruvasile novelnphenylcarbamothioylbenzamideswithantiinflammatoryactivityandprostaglandine2inhibitoryproperties AT fahelelbomkhairimustafasalem novelnphenylcarbamothioylbenzamideswithantiinflammatoryactivityandprostaglandine2inhibitoryproperties AT altabakhamoawiamohammad novelnphenylcarbamothioylbenzamideswithantiinflammatoryactivityandprostaglandine2inhibitoryproperties AT caproiumironteodor novelnphenylcarbamothioylbenzamideswithantiinflammatoryactivityandprostaglandine2inhibitoryproperties AT sadekbassem novelnphenylcarbamothioylbenzamideswithantiinflammatoryactivityandprostaglandine2inhibitoryproperties |